首页> 外国专利> Method of Synthesizing and Purifying Dkk Proteins and Dkk Proteins Obtained Thereby

Method of Synthesizing and Purifying Dkk Proteins and Dkk Proteins Obtained Thereby

机译：合成和纯化Dkk蛋白和由此获得的Dkk蛋白的方法

页面导航

摘要
著录项
相似文献

摘要

The invention relates to a novel method of inexpensively synthesizing large quantities of an essentially pure, biologically active, glycosylated Dkk protein, including mammalian and human Dkk proteins (e.g., human Dkk1). The invention further relates to the synthetically produced essentially purified, glycosylated and biologically active Dkk protein, and the characteristics of the protein.

机译：本发明涉及一种廉价地合成大量基本上纯净的，具有生物活性的，糖基化的Dkk蛋白的新方法，该蛋白包括哺乳动物和人的Dkk蛋白（例如人的Dkk 1 ）。本发明进一步涉及合成产生的基本上纯化的，糖基化的和具有生物活性的Dkk蛋白，以及该蛋白的特性。 展开▼

著录项

公开/公告号US2008038775A1

专利类型

公开/公告日2008-02-14

原文格式PDF

申请/专利权人 KRISTINA ALLEN;ANTHONY ANISOWICZ;WEI CHEN;GIRIJA KRISHNAMURTHY;MATTHEW OLSON;
展开▼

申请/专利号US20050593089

发明设计人 KRISTINA ALLEN;ANTHONY ANISOWICZ;GIRIJA KRISHNAMURTHY;MATTHEW OLSON;WEI CHEN;
展开▼

申请日2005-03-23

分类号C12P21/04;C07K14/00;

国家 US

入库时间 2022-08-21 20:13:55

相似文献

专利

外文文献

中文文献

1. 特异性地识别、结合活性结构的REIC/Dkk-3蛋白的抗体、以及使用该抗REIC/Dkk-3抗体的癌治疗的监测 [P] . 中国专利： CN108139404A . 2018-06-08

2. 从表达腺病毒E1A蛋白的细胞中获得唾液酸化增加的重组蛋白质的方法及由此获得的蛋白质 [P] . 中国专利： CN102653772B . 2014.04.02

3. Method for regulating lrp5, lrp6 or hbm activity in a patient, and dkk-wnt pathway in a patient, to modulate bone mass and lipid levels in a patient, to diagnose high or low bone mass and / or high or low lipid levels in a patient to screen a compound that modulates dkk interaction with lrp5, lrp6, hbm or a dkk binding fragment of lrp5, lrp6 or hbm, and dkk with a protein that interacts with dkk, composition, pharmaceutical composition, methods for identifying compounds that modulate dkk and lrp5 / lrp6 / hbm interactions, and for identifying binding partners for a dkk protein, nucleic acid encoding a dkk-interacting peptide protein aptamer , vector, method for detecting a modulating activity of a transgenic animal compound, method for identifying potential compounds that modulate dkk activity, peptide aptamer, antibody or antibody fragment, and methods for identify dkk-interacting proteins by modulating dkk's interaction with the wnt signaling pathway, to identify compounds that modul [P] . BR0209836A . 2004-12-07

机译：调节患者lrp5，lrp6或hbm活性以及患者dkk-wnt途径，调节患者骨量和脂质水平，诊断高或低骨量和/或高或低脂质水平的方法筛选具有与dkk相互作用的蛋白质的，调节dkk与lrp5，lrp6，hbm或lrp5，lrp6或hbm和dkk的dkk结合片段的dkk相互作用的化合物，组成，药物组合物，鉴定可调节dkk和lrp5 / lrp6 / hbm相互作用，以及用于识别dkk蛋白的结合伴侣的方法，编码与dkk相互作用的肽蛋白适体的核酸，载体，用于检测转基因动物化合物调节活性的方法，用于识别可能调节dkk的化合物的方法活性，肽适体，抗体或抗体片段，以及通过调节dkk与wnt信号通路的相互作用来鉴定与dkk相互作用的蛋白质的方法，以鉴定可调节

4. Method of synthesizing and purifying Dkk proteins and Dkk proteins obtained thereby [P] . 美国专利： US7867699B2 . 2011-01-11

机译：合成和纯化Dkk蛋白的方法以及由此获得的Dkk蛋白

5. METHOD OF SYNTHESIZING AND PURIFYING DKK PROTEINS AND DKK PROTEINS OBTAINED THEREBY [P] . 世界知识产权组织专利： WO2005095448A3 . 2006-02-02

机译：合成和纯化DKK蛋白的方法以及由此获得的DKK蛋白

1. "MELD": a bottom-up method to fully de novo sequence purified proteins [C] . Gabriel Mazzucchelli, Tyler Zimmerman, Marie-Alice Meuwis, American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics . 2013

2. OPTIMUM PROTEIN REQUIREMENTS AND OPTIMUM RATIO BETWEEN ANIMAL PROTEIN TO PLANT PROTEIN IN FORMULATED DIETS FOR NILE TILAPIA (TILAPIA NILOTICA L.) (SOYBEAN CONCENTRATE, ANCHOVY FISH MEAL, DIGESTABILITY, SEMI-PURIFIED DIETS, FISH NUTRITION). [D] . ABDELGHANY, ALI EZZELDIN. 1986

3. Structural and functional analysis of Dickkopf 4 (Dkk4): New insights into Dkk evolution and regulation of Wnt signaling by Dkk and Kremen proteins [O] . Saleha Patel, Alice M. Barkell, Deepti Gupta, 2018

4. TNF‑α treatment increases DKK1 protein levels in primary osteoblasts via upregulation of DKK1 mRNA levels and downregulation of miR‑335‑5p [O] . Shanshan Li, Yixin Yin, Liping Yao, 2020

1. Specific Inhibitory Protein Dkk-1 Blocking Wnt/β-catenin Signaling Pathway Improve Protectives Effect on the Extracellular Matrix [J] . Shunan YE ,Jing WANG ,Shuhua YANG . 华中科技大学学报（医学）（英德文版） . 2011,第005期

2. BACKGROUND： Vibrio vulnifi cus inside the body could activate the NF-!B signaling pathwayand initiate the inflammatory cascade. The lung is one of the earliest organs affected by sepsisassociated with acute lung injury. High mobility group protein B1 （HMGB1） is an important late-actingpro-infl ammatory cytokine involving in the pathophysiology of sepsis. It is also involved in the injuryprocess in the lung, liver and intestine. There has been no report on the involvement of HMGB1 inVibrio vulnifi cus sepsis-induced lung injury.METHODS： Sixty rats were randomly divided into a normal control group （group A, n=10） anda Vibrio vulnificus sepsis group （group B, n=50）. Sepsis was induced in the rats by subcutaneousinjection of Vibrio vulnificus （concentration 6×108 cfu/mL, volume 0.1 mL/100g）） into the left lowerlimbs. The rats in group B were sacrifi ced separately 1, 6, 12, 24, and 48 hours after the infection.Their lungs were stored as specimens, lung water content was measured, and lung pathology wasobserved under a light microscope. The expressions of the HMGB1 gene and protein in the lungswere detected by RT-PCR and Western blot. Data were analyzed with one-way analysis of variance（ANOVA） and the LSD method for pair-wise comparison between the two groups. P〈0.05 wasconsidered statistically signifi cant.RESULTS： Compared to group A （0.652±0.177）, HMGB1 mRNA expression in the lungs ofgroup B was signifi cantly higher at 0 hour （1.161±0.358, P=0.013）, 24 hours （1.679±0.235, P=0.000）,and 48 hours （1.258±0.274, P=0.004）（P〈0.05）, and peaked at 24 hours. Compared to group A（0.594±0.190）, HMGB1 protein expression at 6 hours （1.408±0.567, P=0.026） after infection wassignificantly increased （P〈0. 05）, and peaked at 24 hours （2.415±1.064, P=0.000） after infection.Compared to group A （0.699±0.054）, lung water content was significantly increased at 6 hours（0.759±0.030, P=0.001）,12 hours （0.767±0.023, P=0.000）, 24 hours （0.771±0.043, P=0.000） and 48hours （0.789±0.137, P=0.000） after infection （P〈0.05）. Compared to group A, pathological changesat 12 hours in group B indicate marked pulmonary vascular congestion, interstitial edema andinfl ammatory infi ltration. Alveolar cavity collapse and boundaries of the alveolar septum could not beclearly identifi ed.CONCLUSION： Vibrio vulnifi cus sepsis can lead to injury in rat lungs, and increased HMGB1expression in lung tissue may be one of the mechanisms for injury from Vibrio vulnifi cus sepsis. [J] . Qiao-meng Qiu ,Zhong-wang Li ,Lu-ming Tang . 世界急诊医学杂志(英文) . 2011,第4期

3. Purified Wheat Gliadin Proteins as Immunoglobulin E Binding Factors in Wheat Mediated Allergies [J] . Jacek Waga ,Krystyna Obtulowicz ,Jerzy Zientarski . 美国植物学期刊（英文） . 2011,第3期

4. Protein Quality Evaluation of Animal Food Proteins by iIn-Vitro/iMethodologies [J] . Jesús Manuel Barrón-Hoyos ,Adrian Rafael Archuleta ,María del Refugio Falcón-Villa . 食品与营养科学（英文） . 2013,第4期

5. A robust protein extraction method for two dimensional electrophoresis of silkworm proteins [J] . Lvgao Qin ,Haifeng Shi ,Hengchuan Xia . 生命科学与技术进展（英文） . 2013,第4期

6. Wnt/β-catenin信号通路及其拮抗蛋白DKK1在骨骼发育和骨代谢中的作用 [C] . 黄平 ,金红婷 . 第十届中国南方骨质疏松论坛暨重庆市医学会骨质疏松年会 . 2014

7. 雷公藤多苷片治疗强直性脊柱炎对血清DKK1蛋白水平及外周血单个核细胞DKK1mRNA表达的影响 [A] . 钟灵毓 . 2014